Los Angeles Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.9M | Buy |
|
|||||
|
2025
Q2 | $14.7M | Buy |
|
|||||
|
2025
Q1 | $12.5M | Buy |
|
|||||
|
2024
Q4 | $524K | Sell |
|
|||||
|
2024
Q3 | $8.71M | Sell |
|
|||||
|
2024
Q2 | $30.3M | Sell |
|
|||||
|
2024
Q1 | $55.5M | Sell |
|
|||||
|
2023
Q4 | $159M | Sell |
|
|||||
|
2023
Q3 | $149M | Buy |
|
|||||
|
2023
Q2 | $150M | Sell |
|
|||||
|
2023
Q1 | $144M | Buy |
|
|||||
|
2022
Q4 | $129M | Buy |
|
|||||
|
2022
Q3 | $126M | Buy |
|
|||||
|
2022
Q2 | $95.1M | Sell |
|
|||||
|
2022
Q1 | $92.6M | Buy |
|
|||||
|
2021
Q4 | $66.3M | Buy |
|
|||||
|
2021
Q3 | $28M | Sell |
|
|||||
|
2021
Q2 | $34.1M | Sell |
|
|||||
|
2021
Q1 | $48.2M | Sell |
|
|||||
|
2020
Q4 | $72.6M | Sell |
|
|||||
|
2020
Q3 | $86.1M | Sell |
|
|||||
|
2020
Q2 | $96.6M | Buy |
|
|||||
|
2020
Q1 | $73.9M | Buy |
|
|||||
|
2019
Q4 | $67M | Sell |
|
|||||
|
2019
Q3 | $65M | Sell |
|
|||||
|
2019
Q2 | $79.6M | Sell |
|
|||||
|
2019
Q1 | $80M | Sell |
|
|||||
|
2018
Q4 | $73.2M | Sell |
|
|||||
|
2018
Q3 | $104M | Buy |
|
|||||
|
2018
Q2 | $91.6M | Buy |
|
|||||
|
2018
Q1 | $51.6M | Sell |
|
|||||
|
2017
Q4 | $47.9M | Buy |
|
|||||
|
2017
Q3 | $13M | Buy |
|
|||||
|
2017
Q2 | $465K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $1.71M | Sell |
|
|||||
|
2016
Q3 | $15.5M | Sell |
|
|||||
|
2016
Q2 | $16.3M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $266K | Sell |
|
|||||
|
2015
Q3 | $462K | Sell |
|
|||||
|
2015
Q2 | $40.7M | Buy |
|
|||||
|
2015
Q1 | $36.8M | Buy |
|
|||||
|
2014
Q4 | $299K | Hold |
|
|||||
|
2014
Q3 | $282K | Hold |
|
|||||
|
2014
Q2 | $238K | Sell |
|
|||||
|
2014
Q1 | $5.85M | Sell |
|
|||||
|
2013
Q4 | $8.46M | Sell |
|
|||||
|
2013
Q3 | $12.7M | Buy |
|
|||||
|
2013
Q2 | $858K | Buy |
|